-
Crystallographic data collection and refinement statistics.
*Values in parentheses are for highest-resolution shell.aRmerge = Σh Σi|Ii(h)−<I(h)>/|Σh Σi Ii(h), where I is the observed intensity and <I> is the average intensity... -
Demographic data
**P<0.01; SD, standard deviation; Max/Min, maximal/minimal.The number of participants did not differ between genders (Chi-square P>0.05). The dancer and pianist groups... -
Detection of florfenicol and florfenicol amine residues in chicken eggs
The aim of this study was to develop a suitable method for the analysis of florfenicol (FF) and its metabolite florfenicol amine (FFA) in chicken eggs and to determine FF and... -
Demographic and clinical characteristics of study participants.
¶Non-reactive to methacholine up to a dose of 1.96 mg.¶¶One individual, not subjected to methacholine, was selected based on FEV1 reversability with a value of 25%.¶¶¶Budesonide... -
Clinical and biochemical characteristics of the study subjects.
All values are means ± SD for continuous parametric variables, median (interquartile range) for continuous nonparametric variables, or n (%) for categorical variables.... -
Characteristics of the participants.
Abbreviations: SD, standard deviation; BMI, body mass index; WC, waist circumference; WHtR, waist-to-height ratio; HDL-c, high-density lipoprotein cholesterol; LDL-c,... -
Baseline characteristics of participants.
Data are presented as mean±SD, median (interquartile range) or percent. Chi-square test for categorical variables, the unpaired t test or Mann-Whitney U test for continuous... -
Demographic characteristics of subjects.
Mean (SD) values of demographic characteristics of hemiplegic patients and healthy subjects. For clinical examination, median values are presented (mean and standard deviation... -
Meta-analysis of clinical dose response in a large drug development portfolio
Results of a meta-analysis are reported based on dose response studies conducted by a large pharmaceutical company between 1998-2009. Data collection targeted efficacy endpoints... -
Characteristics of the included trials.
Abbreviations a. A = the primary PCI alone group, B = the immediate or early PCI group b. low risk, i.e., if they were < 60 years old and had a localized inferior infarction... -
Patient data.
Detailed clinical, electrodiagnostic and sonographic findings of all patients. (AD—active denervation, APD—anterior-posterior diameter, BR—brachioradialis muscle, ECR—extensor... -
Baseline subject characteristics.
Values are number (column-%) or means (SD). [1] Lymphoproliferative cancer defined as Hodgkin's lymphoma, non-Hodgkin lymphoma and chronic lymphocytic leukemia, [2] Calculated... -
Characteristics of the study participants.
The continuous variables are presented as mean (SD) and p-value (t-test). The discrete variables are presented as frequency (%) and p-value (χ2 -test). In Model 1A, HTN is... -
Characteristics of study subjects.
JA-1, first-generation Japanese-Americans; JA-2, second- or later-generation Japanese-Americans; BMI, body mass index; BP, blood pressure; 2-h, two-hour post-load; HOMA-IR,... -
Primers used in this study.
a Liu et al., 2011 [19]. b Ji et al., 2007 [20]. c Wei et al., 2010 [21]. d Noteborn et al., 2013 [22]. *Positions correspond to: IBDV (JQ684022), IBV (KJ425500), AEV... -
Characteristics of the study population.
SD = standard deviation; BMI = body mass index; BFP = Body fat percentage measured with bioelectrical impedance [24]; WHR = waist-hip ratio; HGS = handgrip strength, the highest... -
Baseline characteristics of the study subjects.
Continuous variables are expressed as mean (SD), categorical variables are expressed as n (%). Significant results are shown in bold typeface. a Refers to regular use.... -
Characteristics of the study subjects.
All values except number of subjects, gender and smoking status are expressed as median values with minimum and maximum range in parentheses. Ex-smoker: stopped smoking for at...
